Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Zonisamide (Zonegran) for Epilepsy
The Medical Letter 42:94-95, , 2000
Osteoporosis in Neurological Disorders
JNNP 68:543-549, Lloyd,M.E.,et al, 2000
Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000
Adverse Effect of Anticonvulsants on Efficacy of Chemotherapy for Acute Lymphoblastic Leukaemia
Lancet 356:285-290, Relling,M.V. et al, 2000
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000
Levetiracetam for Partial Seizures: Results of A Double-Blind, Randomized Clinical Trial
Neurol 55:236-242, Cereghino,J.J. et al, 2000
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000
Hypothermia and Thermoregulatory Derangements Induced by Valproic Acid
Neurol 55:150-151, Zachariah,S.B. et al, 2000
Visual Function Loss From Vigabatrin
Neurol 55:40-45, Johnson,M.A. et al, 2000
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Prolongation of Midazolam Half-Life After Sustained Infusion for Status Epilepticus
Neurol 54:1366-1368, Naritoku,D.K.&Sinha,S., 2000
Vocal Cord Adduction During Vagus Nerve Stimulation for Treatment of Epilepsy
Neurol 54:1388-1389, Zumsteg,D.,et al, 2000
Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Gabapentin-Induced Anorgasmia
Neurol 53:2209, Clark,J.D.&Elliott,J., 1999
Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999
Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999
Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis During First Weeks of Antiepileptic Therapy:A Case-Control Study
Lancet 353:2190-2194, Rzany,B.,et al, 1999
Vigabatrin, a Gabaergic Antiepileptic Drug, Causes Concentric Visual Field Defects
Neurol 53:922-926, Kalviainen,R.,et al, 1999
Multisystem Hypersensitivity Reaction to Lamotrigine
Neurol 53:1367, Sarris,B.M.&Wong,J.G., 1999
Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999
Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999
The Association of the Combination of Sumatriptan and Methysergide in Myocardial Infarction in a Premenopausal Woman
Arch Int Med 159:511-513, Liston,H.,et al, 1999
Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999
Cognitive Effects of Topiramate,Gabapentin,And Lamotrigine in Healthy Young Adults
Neurol 52:321-327, Martin,R.,et al, 1999
Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999
Agranulocytosis Associated with Lamotrigine
BMJ 318:1179, DeCamargo,O.A.K., 1999
Lamotrigine-Induced Tourettism
Neurol 52:1191-1194, Lombroso,C.T., 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Open Comparative Long-Term Study of Vigabatrin vs Carbamazepine in Newly Diagnosed Partial Seizures in Children
Arch Neurol 56:605-607, Zamponi,N.&Cardinali,C., 1999
Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999
Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999
Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999
A Randomized, Placebo-Controlled Study of Topiramate in Primary Generalized Tonic-Clonic Seizures
Neurol 52:1330-1337, Biton,V.,et al, 1999
Drug Points, Transient Hemiparesis with Topiramate
BMJ 318:845, Stephen,L.J.,et al, 1999
Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999
Oxcarbazepine: Double-blind, Randomized, Placebo-control, Monotherapy Trial for Partial Seizures
Neurol 52:732-737, Schachter,S.C. et al, 1999
Drug Interactions with Methadone
Presse Med 27:1381-1384, Schlatter,J.,et al, 1999
Herbal Remedies: Adverse Effects and Drug Interactions
Am Fam Physician 59:1239-1244, Cupp, M.J.,et al, 1999
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998
Parenteral Fosphenytoin:Efficacy and Economic Considerations
The Neurologist 4:S30-S34, Ramsay,R.E.&Wilder,B.J., 1998
New Antiepileptic Drugs
Arch Neurol 55:1181-1183, Bourgeois,B.F.D., 1998